Incyte Corp. closed 18.70% short of its 52-week high of $83.95, which the company achieved on November 8th.

Shares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for sev ...

The drug is indicated for the treatment of alopecia areata - a condition in which the immune system attacks hair follicles, ...